Louisiana State Employees Retirement System bought a new position in shares of Medpace Holdings Inc (NASDAQ:MEDP) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 9,700 shares of the company’s stock, valued at approximately $572,000.

Several other large investors have also modified their holdings of MEDP. LS Investment Advisors LLC bought a new position in shares of Medpace during the fourth quarter worth about $46,000. SHANDA ASSET MANAGEMENT HOLDINGS Ltd bought a new position in shares of Medpace during the fourth quarter worth about $87,000. State of Alaska Department of Revenue bought a new position in shares of Medpace during the fourth quarter worth about $92,000. NumerixS Investment Technologies Inc bought a new position in shares of Medpace during the fourth quarter worth about $119,000. Finally, We Are One Seven LLC bought a new position in shares of Medpace during the fourth quarter worth about $130,000. 82.84% of the stock is currently owned by institutional investors.

Several equities analysts have recently commented on MEDP shares. BidaskClub lowered shares of Medpace from a “strong-buy” rating to a “buy” rating in a research report on Friday, February 8th. ValuEngine lowered shares of Medpace from a “buy” rating to a “hold” rating in a research report on Tuesday, April 16th. Wolfe Research started coverage on shares of Medpace in a research report on Tuesday, April 2nd. They set an “outperform” rating for the company. TheStreet lowered shares of Medpace from a “b” rating to a “c” rating in a research report on Friday, March 22nd. Finally, Zacks Investment Research lowered shares of Medpace from a “hold” rating to a “sell” rating in a research report on Saturday, March 2nd. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and five have issued a buy rating to the stock. The company has an average rating of “Buy” and an average price target of $55.33.

Shares of MEDP opened at $55.08 on Tuesday. The stock has a market capitalization of $1.95 billion, a P/E ratio of 21.27, a P/E/G ratio of 1.71 and a beta of 1.62. The company has a debt-to-equity ratio of 0.18, a current ratio of 0.69 and a quick ratio of 0.69. Medpace Holdings Inc has a 52-week low of $35.00 and a 52-week high of $71.66.

Medpace (NASDAQ:MEDP) last announced its earnings results on Monday, February 25th. The company reported $0.76 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.69 by $0.07. The firm had revenue of $192.12 million during the quarter, compared to analyst estimates of $184.66 million. Medpace had a net margin of 11.27% and a return on equity of 17.66%. Medpace’s revenue was up 70.5% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.39 EPS. Equities research analysts expect that Medpace Holdings Inc will post 2.64 EPS for the current fiscal year.

In related news, General Counsel Stephen P. Ewald sold 7,946 shares of the stock in a transaction dated Friday, March 29th. The shares were sold at an average price of $57.95, for a total value of $460,470.70. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Jesse J. Geiger sold 25,037 shares of the stock in a transaction dated Monday, April 1st. The shares were sold at an average price of $60.00, for a total transaction of $1,502,220.00. Following the completion of the transaction, the chief financial officer now owns 25,037 shares of the company’s stock, valued at approximately $1,502,220. The disclosure for this sale can be found here. Insiders sold a total of 669,922 shares of company stock valued at $42,460,777 in the last quarter. 29.50% of the stock is currently owned by insiders.

COPYRIGHT VIOLATION NOTICE: This news story was first published by Watch List News and is the property of of Watch List News. If you are reading this news story on another website, it was illegally stolen and reposted in violation of United States & international trademark and copyright law. The legal version of this news story can be viewed at https://www.watchlistnews.com/9700-shares-in-medpace-holdings-inc-medp-purchased-by-louisiana-state-employees-retirement-system/2982041.html.

Medpace Profile

Medpace Holdings, Inc, a clinical contract research organization, provides scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries worldwide. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in a range of therapeutic areas.

Read More: Gap Down Stocks

Want to see what other hedge funds are holding MEDP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medpace Holdings Inc (NASDAQ:MEDP).

Institutional Ownership by Quarter for Medpace (NASDAQ:MEDP)

Receive News & Ratings for Medpace Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medpace and related companies with MarketBeat.com's FREE daily email newsletter.